Report cover image

Global Sorafenib Tablet Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Jul 08, 2025
Length 193 Pages
SKU # APRC20283632

Description

Summary

According to APO Research, The global Sorafenib Tablet market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sorafenib Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Sorafenib Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Sorafenib Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Sorafenib Tablet is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Sorafenib Tablet include Teva, Mylan, Bayer, Natco Pharma, MBA Pharmaceuticals Pvt Ltd, healthiza, Cipla, Aprazer and Aetos Pharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sorafenib Tablet, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Sorafenib Tablet, also provides the sales of main regions and countries. Of the upcoming market potential for Sorafenib Tablet, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sorafenib Tablet sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Sorafenib Tablet market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Sorafenib Tablet sales, projected growth trends, production technology, application and end-user industry.

Sorafenib Tablet Segment by Company

Teva
Mylan
Bayer
Natco Pharma
MBA Pharmaceuticals Pvt Ltd
healthiza
Cipla
Aprazer
Aetos Pharma
Sorafenib Tablet Segment by Type

Patented Drugs
Generic Drugs
Sorafenib Tablet Segment by Application

Kidney Cancer
Other
Thyroid Cancer
Liver Cancer
Sorafenib Tablet Segment by Region

North America
United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sorafenib Tablet market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Sorafenib Tablet and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sorafenib Tablet.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Sorafenib Tablet in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Sorafenib Tablet manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sorafenib Tablet sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

193 Pages
1 Market Overview
1.1 Product Definition
1.2 Sorafenib Tablet Market by Type
1.2.1 Global Sorafenib Tablet Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Patented Drugs
1.2.3 Generic Drugs
1.3 Sorafenib Tablet Market by Application
1.3.1 Global Sorafenib Tablet Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Kidney Cancer
1.3.3 Other
1.3.4 Thyroid Cancer
1.3.5 Liver Cancer
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Sorafenib Tablet Market Dynamics
2.1 Sorafenib Tablet Industry Trends
2.2 Sorafenib Tablet Industry Drivers
2.3 Sorafenib Tablet Industry Opportunities and Challenges
2.4 Sorafenib Tablet Industry Restraints
3 Global Market Growth Prospects
3.1 Global Sorafenib Tablet Revenue Estimates and Forecasts (2020-2031)
3.2 Global Sorafenib Tablet Revenue by Region
3.2.1 Global Sorafenib Tablet Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Sorafenib Tablet Revenue by Region (2020-2025)
3.2.3 Global Sorafenib Tablet Revenue by Region (2026-2031)
3.2.4 Global Sorafenib Tablet Revenue Market Share by Region (2020-2031)
3.3 Global Sorafenib Tablet Sales Estimates and Forecasts 2020-2031
3.4 Global Sorafenib Tablet Sales by Region
3.4.1 Global Sorafenib Tablet Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Sorafenib Tablet Sales by Region (2020-2025)
3.4.3 Global Sorafenib Tablet Sales by Region (2026-2031)
3.4.4 Global Sorafenib Tablet Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Sorafenib Tablet Revenue by Manufacturers
4.1.1 Global Sorafenib Tablet Revenue by Manufacturers (2020-2025)
4.1.2 Global Sorafenib Tablet Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Sorafenib Tablet Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Sorafenib Tablet Sales by Manufacturers
4.2.1 Global Sorafenib Tablet Sales by Manufacturers (2020-2025)
4.2.2 Global Sorafenib Tablet Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Sorafenib Tablet Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Sorafenib Tablet Sales Price by Manufacturers (2020-2025)
4.4 Global Sorafenib Tablet Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Sorafenib Tablet Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Sorafenib Tablet Manufacturers, Product Type & Application
4.7 Global Sorafenib Tablet Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Sorafenib Tablet Market CR5 and HHI
4.8.2 2024 Sorafenib Tablet Tier 1, Tier 2, and Tier 3
5 Sorafenib Tablet Market by Type
5.1 Global Sorafenib Tablet Revenue by Type
5.1.1 Global Sorafenib Tablet Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Sorafenib Tablet Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Sorafenib Tablet Revenue Market Share by Type (2020-2031)
5.2 Global Sorafenib Tablet Sales by Type
5.2.1 Global Sorafenib Tablet Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Sorafenib Tablet Sales by Type (2020-2031) & (K Units)
5.2.3 Global Sorafenib Tablet Sales Market Share by Type (2020-2031)
5.3 Global Sorafenib Tablet Price by Type
6 Sorafenib Tablet Market by Application
6.1 Global Sorafenib Tablet Revenue by Application
6.1.1 Global Sorafenib Tablet Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Sorafenib Tablet Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Sorafenib Tablet Revenue Market Share by Application (2020-2031)
6.2 Global Sorafenib Tablet Sales by Application
6.2.1 Global Sorafenib Tablet Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Sorafenib Tablet Sales by Application (2020-2031) & (K Units)
6.2.3 Global Sorafenib Tablet Sales Market Share by Application (2020-2031)
6.3 Global Sorafenib Tablet Price by Application
7 Company Profiles
7.1 Teva
7.1.1 Teva Comapny Information
7.1.2 Teva Business Overview
7.1.3 Teva Sorafenib Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Teva Sorafenib Tablet Product Portfolio
7.1.5 Teva Recent Developments
7.2 Mylan
7.2.1 Mylan Comapny Information
7.2.2 Mylan Business Overview
7.2.3 Mylan Sorafenib Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Mylan Sorafenib Tablet Product Portfolio
7.2.5 Mylan Recent Developments
7.3 Bayer
7.3.1 Bayer Comapny Information
7.3.2 Bayer Business Overview
7.3.3 Bayer Sorafenib Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Bayer Sorafenib Tablet Product Portfolio
7.3.5 Bayer Recent Developments
7.4 Natco Pharma
7.4.1 Natco Pharma Comapny Information
7.4.2 Natco Pharma Business Overview
7.4.3 Natco Pharma Sorafenib Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Natco Pharma Sorafenib Tablet Product Portfolio
7.4.5 Natco Pharma Recent Developments
7.5 MBA Pharmaceuticals Pvt Ltd
7.5.1 MBA Pharmaceuticals Pvt Ltd Comapny Information
7.5.2 MBA Pharmaceuticals Pvt Ltd Business Overview
7.5.3 MBA Pharmaceuticals Pvt Ltd Sorafenib Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 MBA Pharmaceuticals Pvt Ltd Sorafenib Tablet Product Portfolio
7.5.5 MBA Pharmaceuticals Pvt Ltd Recent Developments
7.6 healthiza
7.6.1 healthiza Comapny Information
7.6.2 healthiza Business Overview
7.6.3 healthiza Sorafenib Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 healthiza Sorafenib Tablet Product Portfolio
7.6.5 healthiza Recent Developments
7.7 Cipla
7.7.1 Cipla Comapny Information
7.7.2 Cipla Business Overview
7.7.3 Cipla Sorafenib Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Cipla Sorafenib Tablet Product Portfolio
7.7.5 Cipla Recent Developments
7.8 Aprazer
7.8.1 Aprazer Comapny Information
7.8.2 Aprazer Business Overview
7.8.3 Aprazer Sorafenib Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Aprazer Sorafenib Tablet Product Portfolio
7.8.5 Aprazer Recent Developments
7.9 Aetos Pharma
7.9.1 Aetos Pharma Comapny Information
7.9.2 Aetos Pharma Business Overview
7.9.3 Aetos Pharma Sorafenib Tablet Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Aetos Pharma Sorafenib Tablet Product Portfolio
7.9.5 Aetos Pharma Recent Developments
8 North America
8.1 North America Sorafenib Tablet Market Size by Type
8.1.1 North America Sorafenib Tablet Revenue by Type (2020-2031)
8.1.2 North America Sorafenib Tablet Sales by Type (2020-2031)
8.1.3 North America Sorafenib Tablet Price by Type (2020-2031)
8.2 North America Sorafenib Tablet Market Size by Application
8.2.1 North America Sorafenib Tablet Revenue by Application (2020-2031)
8.2.2 North America Sorafenib Tablet Sales by Application (2020-2031)
8.2.3 North America Sorafenib Tablet Price by Application (2020-2031)
8.3 North America Sorafenib Tablet Market Size by Country
8.3.1 North America Sorafenib Tablet Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Sorafenib Tablet Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Sorafenib Tablet Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Sorafenib Tablet Market Size by Type
9.1.1 Europe Sorafenib Tablet Revenue by Type (2020-2031)
9.1.2 Europe Sorafenib Tablet Sales by Type (2020-2031)
9.1.3 Europe Sorafenib Tablet Price by Type (2020-2031)
9.2 Europe Sorafenib Tablet Market Size by Application
9.2.1 Europe Sorafenib Tablet Revenue by Application (2020-2031)
9.2.2 Europe Sorafenib Tablet Sales by Application (2020-2031)
9.2.3 Europe Sorafenib Tablet Price by Application (2020-2031)
9.3 Europe Sorafenib Tablet Market Size by Country
9.3.1 Europe Sorafenib Tablet Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Sorafenib Tablet Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Sorafenib Tablet Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Sorafenib Tablet Market Size by Type
10.1.1 China Sorafenib Tablet Revenue by Type (2020-2031)
10.1.2 China Sorafenib Tablet Sales by Type (2020-2031)
10.1.3 China Sorafenib Tablet Price by Type (2020-2031)
10.2 China Sorafenib Tablet Market Size by Application
10.2.1 China Sorafenib Tablet Revenue by Application (2020-2031)
10.2.2 China Sorafenib Tablet Sales by Application (2020-2031)
10.2.3 China Sorafenib Tablet Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Sorafenib Tablet Market Size by Type
11.1.1 Asia Sorafenib Tablet Revenue by Type (2020-2031)
11.1.2 Asia Sorafenib Tablet Sales by Type (2020-2031)
11.1.3 Asia Sorafenib Tablet Price by Type (2020-2031)
11.2 Asia Sorafenib Tablet Market Size by Application
11.2.1 Asia Sorafenib Tablet Revenue by Application (2020-2031)
11.2.2 Asia Sorafenib Tablet Sales by Application (2020-2031)
11.2.3 Asia Sorafenib Tablet Price by Application (2020-2031)
11.3 Asia Sorafenib Tablet Market Size by Country
11.3.1 Asia Sorafenib Tablet Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Sorafenib Tablet Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Sorafenib Tablet Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Sorafenib Tablet Market Size by Type
12.1.1 SAMEA Sorafenib Tablet Revenue by Type (2020-2031)
12.1.2 SAMEA Sorafenib Tablet Sales by Type (2020-2031)
12.1.3 SAMEA Sorafenib Tablet Price by Type (2020-2031)
12.2 SAMEA Sorafenib Tablet Market Size by Application
12.2.1 SAMEA Sorafenib Tablet Revenue by Application (2020-2031)
12.2.2 SAMEA Sorafenib Tablet Sales by Application (2020-2031)
12.2.3 SAMEA Sorafenib Tablet Price by Application (2020-2031)
12.3 SAMEA Sorafenib Tablet Market Size by Country
12.3.1 SAMEA Sorafenib Tablet Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Sorafenib Tablet Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Sorafenib Tablet Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Sorafenib Tablet Value Chain Analysis
13.1.1 Sorafenib Tablet Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Sorafenib Tablet Production Mode & Process
13.2 Sorafenib Tablet Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Sorafenib Tablet Distributors
13.2.3 Sorafenib Tablet Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.